PharmaVoice

Pharma Tech

Sino and AstraZeneca sign licence agreement for TQC3721

AstraZeneca and Sino Biopharmaceutical's subsidiary CTTQ have signed an exclusive licence agreement for TQC3721.

Pharma Tech

Evogene and Tel Aviv University launch drug discovery initiative

Evogene and Tel Aviv University’s BCDD have partnered to expedite small-molecule drug discovery originating from Israeli academic research.

Read Full Article

Pharma Tech

FDA cracks down on illegal ketamine sellers amid nearing ‘psychedelic revolution’

The FDA is taking action to curb the illicit online trade of unregulated and unapproved ketamine products through a slew of warning letters.

Read Full Article

Pharma Tech

Kalohexis confidentially files IPO to back obesity and cachexia portfolio

The biotech’s potential launch on the public markets would help fuel development of its clinical-stage, melanocortin-focused pipeline.

Read Full Article

Pharma Tech

Novo Nordisk signs pact with Vivani for long-lasting semaglutide implant

Vivani’s NanoPortal technology delivers medication steadily over long periods of time.

Read Full Article

Featured promotional

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

ET Pharma

Jul 9, 2026, 1:30 PM

Dr Reddy’s halts semaglutide supply over impurities in API

Commercial distribution of the product will be completely halted for the remainder of the current quarter. However, no resubmissions or approvals are required from the relevant regulatory authorities to resume commercialisation.

Read

PharmaShots

Jul 9, 2026, 1:30 PM

PharmaShots Magazine-July-2026 Edition

Shots: The post PharmaShots Magazine-July-2026 Edition appeared first on PharmaShots.

Read

PharmaShots

Jul 9, 2026, 12:30 PM

CervoMed Completes Patient Enrollment in P-IIa Study of Neflamapimod for Nonfluent Variant Primary Progressive Aphasia

Shots: Ref: Globenewswire | Image: CervoMed | Press Release Related News: Ionis Completes Patient Enrollment in Cohort 1 of P-III (REVEAL) Study of Obudanersen in Angelman syndrome (AS) PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post CervoMed Completes Patient Enrollment in P-IIa Study of Neflamapimod for Nonfluent Variant Primary Progressive Aphasia appeared first on PharmaShots.

Read

PharmaShots

Jul 9, 2026, 11:30 AM

Ipsen Reports Topline P-III (BEOND) Trial Program Data on Dysport in Both Episodic and Chronic Migraine

Shots: Ref: Globenewswire | Image: Ipsen | Press Release Related News: Ipsen to Acquire Memo Therapeutics for >€700M PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Ipsen Reports Topline P-III (BEOND) Trial Program Data on Dysport in Both Episodic and Chronic Migraine appeared first on PharmaShots.

Read

PharmaShots

Jul 9, 2026, 10:30 AM

Roche Receives CE Mark for Rapid Elecsys IGRA TB Test to Detect Latent Tuberculosis

Shots: Ref: Globenewswire | Image: Roche | Press Release Related News: Roche’s Elecsys pTau217 Test Receives the European CE Mark Approval to Rule in or Rule Out Alzheimer’s-Related Amyloid Pathology PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Roche Receives CE Mark for Rapid Elecsys IGRA TB Test to Detect Latent Tuberculosis appeared first on PharmaShots.

Read

Pharma Tech

Jul 9, 2026, 9:48 AM